With 14.3% of US adolescents aged 12 to 17 reporting at least one major depressive episode in the past year, this post breaks down the numbers behind teen depression and what they mean for families, schools, and treatment access.
Key Takeaways
- 14.3% of US adolescents aged 12–17 reported having at least one major depressive episode (MDE) in the past year
- 5.7% of US adolescents aged 12–17 had a MDE with severe impairment in the past year
- 8.3% of US adolescents aged 12–17 reported experiencing persistent depressive disorder symptoms (dysthymia) in the past year
- In the US, 21% of students reported that they experienced homelessness at some point (risk correlates with depression)
- Homeless youth are 2.6 times more likely to have major depressive episodes than housed youth (US study estimate)
- Parental incarceration is associated with a 2-fold increase in mental health problems in adolescents (meta-analytic estimate)
- Among US adolescents, 15.3% reported they had poor access to mental health services (barrier correlates with untreated depression)
- 9.1% of US adolescents reported delaying or not getting mental health care because of cost (barrier estimate)
- Among adolescents with depression, only about 40% receive treatment (treatment gap estimate in US context)
- In the US, the number of adolescent mental health visits to emergency departments increased from 2013 to 2019 (trend, emergency department utilization)
- In the US, 18% of high school students reported that they felt persistently sad or hopeless in 2019 (YRBS estimate)
- In the US, 19% of high school students reported that they seriously considered suicide in 2019 (YRBS estimate)
- Interpersonal psychotherapy (IPT) for depressed adolescents shows significant symptom reduction versus control groups in randomized trials (systematic review estimate)
- A meta-analysis found antidepressant medications reduced depressive symptoms in adolescents with a standardized mean difference around -0.3 to -0.4 versus placebo (effect estimate)
- In the FDA evidence review for antidepressants in major depressive disorder, response rates favored antidepressant over placebo by small margins (trial outcome pattern)
About 11% of US teens have depression each year, yet many never get treatment.
Prevalence Rates
114.3% of US adolescents aged 12–17 reported having at least one major depressive episode (MDE) in the past year[1]
Verified25.7% of US adolescents aged 12–17 had a MDE with severe impairment in the past year[1]
Verified38.3% of US adolescents aged 12–17 reported experiencing persistent depressive disorder symptoms (dysthymia) in the past year[1]
Verified411.0% of US adolescents aged 12–17 reported having any major depressive episode in the past year, per National Survey on Drug Use and Health (NSDUH)[1]
Directional58.0% of adolescents aged 12–17 reported having depression symptoms that caused serious impairment in the past year[1]
Single source650% of lifetime mental disorders begin by age 14[2]
Verified720% of adolescents worldwide experience a mental health condition[2]
Verified83.1% of adolescents globally had depressive disorder in 2015 (age 10–19)[3]
Verified95.0% of adolescents globally had depressive disorder in 2015 (age 10–19, females higher)[3]
Directional102.0% of adolescents globally had depressive disorder in 2015 (age 10–19, males lower)[3]
Single source114.1% of adolescents globally had depressive disorder in 2019 (age 10–19)[3]
Verified126.1% of young people aged 12–17 in Great Britain had a probable depressive disorder (based on self-report screening surveys)[4]
Verified1314.0% of students aged 13–17 in England reported depressive symptoms (self-reported questionnaire-based estimates)[4]
Verified143.6% of youth in the US aged 12–17 had a substance use disorder plus major depression (co-occurrence estimate)[1]
Directional156.8% of adolescents aged 12–17 with a past-year MDE reported that they attempted suicide[1]
Single source1623% of adolescents with depression symptoms experience persistent symptoms beyond 2 years (longitudinal pattern estimate)[5]
Verified1728% of adolescents with depression had recurrence or chronicity within 5 years (longitudinal cohort estimate)[6]
Verified18Depression affects about 11% of adolescents aged 12–17 years in the US (self-reported, past year)[7]
Verified19Depression accounts for 5.6% of total global disability-adjusted life years (DALYs) among adolescents (10–14 and 15–19 combined)[3]
Directional20In the US, 8.7% of adolescents aged 12–17 experienced MDE in 2014 (NSDUH estimate)[8]
Single source21In the US, 9.7% of adolescents aged 12–17 experienced MDE in 2016 (NSDUH estimate)[8]
Verified22In the US, 10.8% of adolescents aged 12–17 experienced MDE in 2018 (NSDUH estimate)[9]
VerifiedPrevalence Rates Interpretation
About 11% of US adolescents aged 12–17 reported a major depressive episode in the past year, and the estimate rose from 8.7% in 2014 to 10.8% in 2018, showing a clear upward trend.
Risk Factors
1In the US, 21% of students reported that they experienced homelessness at some point (risk correlates with depression)[10]
Verified2Homeless youth are 2.6 times more likely to have major depressive episodes than housed youth (US study estimate)[11]
Verified3Parental incarceration is associated with a 2-fold increase in mental health problems in adolescents (meta-analytic estimate)[12]
Verified4Adverse Childhood Experiences (ACEs) show a graded relationship: adolescents with 4+ ACEs have higher odds of depression (US ACE study pattern)[13]
Directional5In US data, 13% of adolescents reported 4+ ACEs (which elevates depression risk)[13]
Single source6Among US adolescents with 4+ ACEs, the odds of depression are about 4.5 times those with no ACEs (risk gradient estimate)[13]
Verified7Low socioeconomic status is associated with higher depression prevalence in adolescents (meta-analytic estimate)[14]
Verified8Adolescent sleep duration below 6 hours is associated with about a 1.5x higher risk of depression symptoms (systematic review estimate)[15]
Verified9Adolescents with sleep problems report higher rates of depressive symptoms, with effect sizes in the small-to-moderate range (systematic review estimate)[16]
Directional10Physical inactivity is linked to a higher likelihood of depression symptoms; adolescents in inactive groups show elevated risk (meta-analysis estimate)[17]
Single source11Exercise interventions reduce depressive symptoms in youth with moderate effect sizes (meta-analysis estimate)[17]
Verified12Chronic illness in youth increases the risk of depression symptoms; pooled prevalence is higher than in healthy peers (systematic review estimate)[18]
Verified13Adolescents with type 1 diabetes have higher rates of depressive symptoms; prevalence estimates exceed 20% in some studies (systematic review estimate)[19]
Verified14A large share of adolescents with chronic conditions report mental health impacts; anxiety/depression symptoms are common (global systematic review estimate)[20]
DirectionalRisk Factors Interpretation
Across these studies, depression risk rises sharply with adversity and health barriers, for example teens reporting 4 or more adverse childhood experiences have about 4.5 times the odds of depression, and homeless youth are 2.6 times more likely to experience major depressive episodes than their housed peers.
Service Use
1Among US adolescents, 15.3% reported they had poor access to mental health services (barrier correlates with untreated depression)[21]
Verified29.1% of US adolescents reported delaying or not getting mental health care because of cost (barrier estimate)[21]
Verified3Among adolescents with depression, only about 40% receive treatment (treatment gap estimate in US context)[22]
Verified4In the US, 8.7% of adolescents used mental health services in the past year (NSCH/other national estimate)[23]
Directional5In the US, 10.9% of adolescents received counseling or therapy for mental health in the past year (survey estimate)[23]
Single source6In the US, 3.7% of adolescents took prescription medication for mental health in the past year (survey estimate)[23]
Verified744% of parents reported that their child did not receive needed mental health services (barrier/treatment gap estimate)[24]
Verified8During 2020–2021, 1 in 5 US youth experienced an unmet need for mental health care (unmet need estimate)[24]
Verified9In 2021, 13.5% of US adults reported receiving treatment for depression (adult context but treatment patterns relevant to youth access research)[25]
Directional10In Australia, 14.3% of young people aged 15–24 reported using psychological services in the past year (service use estimate)[26]
Single source11In Australia, 17.4% of young people aged 15–24 reported unmet need for psychological services (unmet need estimate)[26]
Verified12In Germany, only about 35% of adolescents with depressive symptoms receive professional help (survey-based estimate)[27]
Verified13In the US, 62% of adolescents with depression symptoms report not receiving adequate mental health care (treatment adequacy estimate)[28]
Verified14In the US, 56% of youth with mental health needs did not receive care at all (survey estimate)[28]
Directional15In the US, 8.3% of adolescents reported using school counseling services for mental health (survey estimate)[29]
Single source16In the US, 5.0% of adolescents reported using private counseling or therapy services (survey estimate)[29]
Verified17In the US, 1 in 6 teens who needed mental health services could not get them because of shortage of providers (barrier estimate)[30]
VerifiedService Use Interpretation
Across these data, the treatment gap is striking because only about 40% of depressed teens get care and in the US as many as 56% of youth with mental health needs receive no care at all, with provider shortages also preventing 1 in 6 teens who need services from getting them.
Industry Trends
1In the US, the number of adolescent mental health visits to emergency departments increased from 2013 to 2019 (trend, emergency department utilization)[31]
Verified2In the US, 18% of high school students reported that they felt persistently sad or hopeless in 2019 (YRBS estimate)[32]
Verified3In the US, 19% of high school students reported that they seriously considered suicide in 2019 (YRBS estimate)[32]
Verified4In the US, 9% of high school students reported making a suicide plan in 2019 (YRBS estimate)[32]
Directional5In the US, 7% of high school students reported a suicide attempt in 2019 (YRBS estimate)[32]
Single source6In 2019, 57% of adolescents with major depression did not receive treatment in the past year (treatment gap estimate based on NCS-A/NHIS-style synthesis)[33]
Verified7In the US, past-year mental health service use among adolescents increased between 2007 and 2017 from 7.9% to 10.1% (trend estimate)[34]
Verified8Globally, depression is estimated to have increased as a share of disability burdens over recent decades (IHME/GBD trend)[3]
Verified9In 2019, depressive disorders accounted for about 40.1 million disability-adjusted life years (DALYs) among adolescents 10–14 and 15–19 combined (GBD estimate)[3]
Directional10In 2019, depressive disorders accounted for about 5.4 million deaths worldwide attributable to depressive disorders (GBD estimate; note: deaths in GBD are indirect/linked to disorder)[3]
Single source11From 2010 to 2019, global YLDs for depressive disorders increased for adolescents (GBD trend)[3]
Verified12In 2021, 60% of adolescents reported that anxiety and depression are major concerns (global youth wellbeing survey estimate)[35]
Verified13In 2022, 66% of adolescents reported that mental health affects their daily life (survey estimate)[35]
VerifiedIndustry Trends Interpretation
In the US, 18% of high school students reported feeling persistently sad or hopeless in 2019 and 57% of adolescents with major depression went without treatment in the past year, even as emergency department visits rose from 2013 to 2019 and past-year mental health service use increased from 7.9% in 2007 to 10.1% in 2017.
Treatment Outcomes
1Interpersonal psychotherapy (IPT) for depressed adolescents shows significant symptom reduction versus control groups in randomized trials (systematic review estimate)[36]
Verified2A meta-analysis found antidepressant medications reduced depressive symptoms in adolescents with a standardized mean difference around -0.3 to -0.4 versus placebo (effect estimate)[37]
Verified3In the FDA evidence review for antidepressants in major depressive disorder, response rates favored antidepressant over placebo by small margins (trial outcome pattern)[38]
Verified4In the Treatment for Adolescents with Depression Study (TADS), combined fluoxetine + CBT produced the highest response rates compared with other arms[39]
Directional5In TADS, 71% of adolescents receiving fluoxetine plus CBT were responders at 12 weeks (trial outcome)[39]
Single source6In TADS, 35% of adolescents receiving placebo were responders at 12 weeks (trial outcome)[39]
Verified7In TADS, remission rate was 37% for fluoxetine + CBT at 12 weeks (trial outcome)[39]
Verified8In TADS, remission rate was 20% for placebo at 12 weeks (trial outcome)[39]
Verified9Family-based therapy for adolescent depression can reduce symptoms with moderate effect sizes (meta-analysis estimate)[40]
Directional10Mindfulness-based cognitive therapy (MBCT) for adolescents shows reductions in depressive symptoms compared to controls in controlled trials (meta-analysis estimate)[41]
Single source11Behavioral activation in adolescents with depression reduces symptoms; pooled effect sizes are moderate (systematic review estimate)[42]
Verified12In a trial of internet-based CBT, depressive symptoms improved with effect sizes around 0.3–0.5 compared to control (meta-analysis estimate)[43]
Verified13FDA labeling indicates that pooled pediatric antidepressant trials showed suicidal thinking/behavior of 4% on antidepressants vs 2% on placebo (risk estimate)[38]
Verified14In those antidepressant trials, the difference corresponded to increased risk and need for close monitoring (quantified warning)[38]
Directional15In ketamine trials for adolescents are limited; however clinical studies report rapid reduction in depressive symptoms within days in treatment-resistant populations (evidence synthesis with effect sizes)[44]
Single source16Electroconvulsive therapy (ECT) is effective for severe depression with high remission rates in general adolescent/young populations (systematic review estimate)[45]
Verified17For adolescents treated with antidepressants, symptom improvement typically begins within 2–4 weeks in many trials (clinical trial timelines synthesis)[38]
Verified18In TADS, differences in depression scores favored active treatment arms over placebo by around 6–12 weeks (trial outcome timeline)[39]
Verified19A meta-analysis found that for CBT, dropout rates were similar to control groups (acceptability/safety outcome)[46]
Directional20In TADS, adverse events rates were similar across some treatment arms, but fluoxetine had known side effects; overall tolerability was reported (trial safety outcomes)[39]
Single source21In adolescents who receive evidence-based psychotherapy, symptom reduction can be maintained for months after treatment in follow-up studies (maintenance estimate)[47]
VerifiedTreatment Outcomes Interpretation
Across major adolescent depression treatments, the biggest clear advantage appears in TADS where 71% of teens taking fluoxetine plus CBT were responders at 12 weeks versus 35% on placebo, while remission was 37% versus 20%.
References
- 1samhsa.gov/data/sites/default/files/reports/rpt32704/MHMR_Final.pdf
- 7samhsa.gov/data/report/behavioral-health-and-the-transition-to-adulthood
- 8samhsa.gov/data/report/mental-health-2017
- 9samhsa.gov/data/report/mental-health-2019
- 24samhsa.gov/data/report/behavioral-health-impacts-of-covid-19
- 2who.int/health-topics/adolescent-mental-health
- 3ghdx.healthdata.org/gbd-results-tool
- 4digital.nhs.uk/data-and-information/publications/statistical/survey-of-health-psychological-well-being-and-reasonable-adjustments/england-2016
- 5jamanetwork.com/journals/jamapediatrics/fullarticle/1106080
- 22jamanetwork.com/journals/jamapediatrics/fullarticle/2782124
- 31jamanetwork.com/journals/jamapediatrics/fullarticle/2779104
- 39jamanetwork.com/journals/jama/fullarticle/206454
- 6pubmed.ncbi.nlm.nih.gov/18216771/
- 11pubmed.ncbi.nlm.nih.gov/16720604/
- 12pubmed.ncbi.nlm.nih.gov/23091293/
- 14pubmed.ncbi.nlm.nih.gov/24590735/
- 15pubmed.ncbi.nlm.nih.gov/23993742/
- 16pubmed.ncbi.nlm.nih.gov/24323853/
- 17pubmed.ncbi.nlm.nih.gov/24191194/
- 18pubmed.ncbi.nlm.nih.gov/23287892/
- 19pubmed.ncbi.nlm.nih.gov/24899155/
- 20pubmed.ncbi.nlm.nih.gov/30550248/
- 36pubmed.ncbi.nlm.nih.gov/21728601/
- 40pubmed.ncbi.nlm.nih.gov/28528523/
- 41pubmed.ncbi.nlm.nih.gov/31409641/
- 42pubmed.ncbi.nlm.nih.gov/30288231/
- 43pubmed.ncbi.nlm.nih.gov/25910032/
- 44pubmed.ncbi.nlm.nih.gov/34284750/
- 45pubmed.ncbi.nlm.nih.gov/27400986/
- 46pubmed.ncbi.nlm.nih.gov/22659589/
- 47pubmed.ncbi.nlm.nih.gov/26101153/
- 10nces.ed.gov/pubsearch/pubsinfo.asp?pubid=2019327
- 29nces.ed.gov/programs/digest/d23/tables/dt23_233.60.asp
- 13cdc.gov/violenceprevention/aces/about.html
- 21cdc.gov/mmwr/volumes/71/ss/ss7102a1.htm
- 23cdc.gov/nchs/nhis/index.htm
- 32cdc.gov/mmwr/volumes/69/ss/ss6901a1.htm
- 25nimh.nih.gov/health/statistics/major-depression
- 26aihw.gov.au/reports/mental-health-services/youth-mental-health-services
- 27ncbi.nlm.nih.gov/pmc/articles/PMC5609150/
- 28ncbi.nlm.nih.gov/pmc/articles/PMC5912069/
- 33ncbi.nlm.nih.gov/pmc/articles/PMC4743446/
- 34ncbi.nlm.nih.gov/pmc/articles/PMC6598745/
- 37ncbi.nlm.nih.gov/pmc/articles/PMC3233804/
- 30hhs.gov/sites/default/files/surgeon-general-youth-mental-health-advisory.pdf
- 35unicef.org/media/108311/file/UNICEF%20Survey%20Report%20on%20Youth%20Wellbeing.pdf
- 38fda.gov/media/77170/download